TELA Bio, Inc. — Form 8-K/A
Filed August 13, 2026 · analyzed by the 8-K Agent
8-K/A
— Neutral
significance 28/100
What the filing says
TELA Bio filed an amended 8-K/A on August 13, 2026, reporting Item 5.02 disclosures concerning departure of directors or officers and compensatory arrangements. The specific amendments, dollar amounts, individuals affected, and nature of compensation changes are not detailed in the filing header or metadata provided.
Why this rating
Amendment to existing disclosure; no concrete new terms, amounts, or material changes disclosed in available text. Routine SEC procedural filing for a $76.8M company.
Extracted items
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.